Moderna target nearly halved by Morgan Stanley on weak guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Morgan Stanley (MS) PT Raised to $151 at Jefferies
January 17, 2025 5:13 AM ESTJefferies analyst Daniel Fannon raised the price target on Morgan Stanley (NYSE: MS) to $151.00 (from $144.00) while maintaining a Buy rating.
The analyst comments "Post 4Q24 results, we increase our EPS est's for 2025/2026 by +2% each to $8.30/$9.15 from $8.15/$9.00 previously. Positive revisions reflect the flow-through of... More
Morgan Stanley (MS) PT Raised to $150 at Evercore ISI
January 17, 2025 5:07 AM ESTEvercore ISI analyst Glenn Schorr raised the price target on Morgan Stanley (NYSE: MS) to $150.00 (from $140.00) while maintaining a Outperform rating.
The analyst comments "While we were way above the street and expecting a big print, MSs $2.22 handily topped our $1.91 estimate thanks to strong results in the IB, client balances and flows continue that to grow (~$8trn client assets and ~5% organic growth), the returns are high (20% in 4Q/19% for the year), theres a lot of excess... More
